THRIVENT FINANCIAL FOR LUTHERANS - VOR BIOPHARMA INC ownership

VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 62 filers reported holding VOR BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
THRIVENT FINANCIAL FOR LUTHERANS ownership history of VOR BIOPHARMA INC
ValueSharesWeighting
Q3 2023$317
-67.2%
149,690
-52.1%
0.00%
-50.0%
Q2 2023$967
-43.0%
312,652
-0.8%
0.00%
-50.0%
Q1 2023$1,696
-16.9%
315,209
+2.7%
0.00%
-20.0%
Q4 2022$2,040
-99.8%
306,811
+1.5%
0.01%
+66.7%
Q3 2022$1,204,000
-15.6%
302,412
+5.4%
0.00%
-25.0%
Q2 2022$1,426,000
-22.8%
286,852
-6.2%
0.00%0.0%
Q1 2022$1,847,000
-48.1%
305,825
-0.1%
0.00%
-42.9%
Q4 2021$3,558,000
-25.3%
306,143
+0.8%
0.01%
-30.0%
Q3 2021$4,764,000
-8.3%
303,798
+9.1%
0.01%
-9.1%
Q2 2021$5,194,000
-56.6%
278,480
+0.3%
0.01%
-57.7%
Q1 2021$11,972,000277,7770.03%
Other shareholders
VOR BIOPHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
5AM Venture Management, LLC 6,361,723$34,226,0708.75%
OUP Management Co., LLC 374,714$2,015,9614.02%
Paradigm Biocapital Advisors LP 6,477,999$34,851,6353.30%
RA Capital Management 22,748,880$122,388,9742.77%
JOHNSON & JOHNSON 1,074,658$5,781,6601.88%
Artal Group S.A. 2,792,805$15,0250.89%
Trustees of Columbia University in the City of New York 91,910$494,4760.88%
Sarissa Capital Management LP 618,000$3,324,8400.42%
Laurion Capital Management LP 3,182,889$17,123,9430.12%
Woodline Partners LP 1,111,123$5,977,8420.08%
View complete list of VOR BIOPHARMA INC shareholders